Literature DB >> 29893032

Silver absorption in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with silver-impregnated dressings. A case series.

Hyunji Choi1, Brianna Castillo2, Lucia Seminario-Vidal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29893032      PMCID： PMC7949585          DOI： 10.1111/iwj.12938

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  18 in total

1.  Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing.

Authors:  José Asz; Daniel Asz; Robin Moushey; Jennifer Seigel; Susan B Mallory; Robert P Foglia
Journal:  J Pediatr Surg       Date:  2006-12       Impact factor: 2.545

2.  Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA.

Authors:  Wenjuan Yang; Cenchao Shen; Qiaoli Ji; Hongjie An; Jinju Wang; Qingdai Liu; Zhizhou Zhang
Journal:  Nanotechnology       Date:  2009-02-02       Impact factor: 3.874

3.  U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Authors:  D Creamer; S A Walsh; P Dziewulski; L S Exton; H Y Lee; J K G Dart; J Setterfield; C B Bunker; M R Ardern-Jones; K M T Watson; G A E Wong; M Philippidou; A Vercueil; R V Martin; G Williams; M Shah; D Brown; P Williams; M F Mohd Mustapa; C H Smith
Journal:  Br J Dermatol       Date:  2016-06       Impact factor: 9.302

4.  Blood and Tissue Silver Levels Following Application of Silver-Based Dressings to Sulfur Mustard Chemical Burns.

Authors:  David J Barillo; Claire R Croutch; Frances Reid; Tara Culley; William Sosna; Julie Roseman
Journal:  J Burn Care Res       Date:  2017 Sep/Oct       Impact factor: 1.845

5.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells.

Authors:  P V AshaRani; Grace Low Kah Mun; Manoor Prakash Hande; Suresh Valiyaveettil
Journal:  ACS Nano       Date:  2009-02-24       Impact factor: 15.881

6.  A Case of Argyria and Acute Leukopenia Associated with the Use of an Antimicrobial Soft Silicone Foam Dressing.

Authors:  Andrew McCague; Victor C Joe
Journal:  J Burn Care Res       Date:  2016 Sep-Oct       Impact factor: 1.845

7.  Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient.

Authors:  Marija Trop; Michael Novak; Siegfried Rodl; Bengt Hellbom; Wolfgang Kroell; Walter Goessler
Journal:  J Trauma       Date:  2006-03

8.  Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles.

Authors:  Kyungeun Cha; Hye-Won Hong; Yeon-Gil Choi; Min Joo Lee; Jong Hoon Park; Hee-Kwon Chae; Gyuha Ryu; Heejoon Myung
Journal:  Biotechnol Lett       Date:  2008-07-05       Impact factor: 2.461

9.  Aquacel Ag with Vaseline gauze in the management of toxic epidermal necrolysis (TEN).

Authors:  Shu-Hung Huang; Pei-Shan Yang; Sheng-Hua Wu; Kao-Ping Chang; Tsai-Ming Lin; Sin-Daw Lin; Chung-Sheng Lai; Su-Shin Lee
Journal:  Burns       Date:  2009-05-27       Impact factor: 2.744

10.  Clinical evaluation comparing the efficacy of aquacel Ag with vaseline gauze versus 1% silver sulfadiazine cream in toxic epidermal necrolysis.

Authors:  Shu-Hung Huang; Cen-Hung Lin; Kao-Ping Chang; Sheng-Hua Wu; Sin-Daw Lin; Chung-Sheng Lai; Su-Fei Ou; Su-Shin Lee
Journal:  Adv Skin Wound Care       Date:  2014-05       Impact factor: 2.347
View more
  2 in total

Review 1.  Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Authors:  Michele L Ramien; Danny Mansour; Neil H Shear
Journal:  Paediatr Drugs       Date:  2022-06-09       Impact factor: 3.022

Review 2.  Self-disinfecting surfaces and infection control.

Authors:  Micaela Machado Querido; Lívia Aguiar; Paula Neves; Cristiana Costa Pereira; João Paulo Teixeira
Journal:  Colloids Surf B Biointerfaces       Date:  2019-02-16       Impact factor: 5.268
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.